Evidence map›Paper›PMID 38412564›Full record

ReviewCurrent opinion in genetics & development2024

Hexasomal particles: consequence or also consequential?

Upneet Kaur, Elise N Muñoz, Geeta J Narlikar

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Upneet KaurDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158, USA; Biophysics Graduate Program, University of California, San Francisco, CA 94158, USA.
Elise N MuñozDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158, USA; Tetrad Graduate Program, University of California, San Francisco, CA 94158, USA.
Geeta J NarlikarDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158, USA. Electronic address: geeta.narlikar@ucsf.edu.
University of California, San Francisco · US

Funding

Measuring the lifetime and mechanical stability of phase-separated heterochromatin domainsR35GM127020 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GEETA J NARLIKAR · 2018 to 2026
$7.3M
Dissecting the unique chaperone mechanism of the Rvb1/Rvb2 AAA+ ATPase complexF31GM142271 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MUÑOZ, ELISE NOELLE · 2021 to 2023
$127k
NIGMS NIH HHS F31 GM142271NIGMS NIH HHS R35 GM127020
6 · The paper itself

Abstract

It is long known that an RNA polymerase transcribing through a nucleosome can generate subnucleosomal particles called hexasomes. These particles lack an H2A-H2B dimer, breaking the symmetry of a nucleosome and revealing new interfaces. Whether hexasomes are simply a consequence of RNA polymerase action or they also have a regulatory impact remains an open question. Recent biochemical and structural studies of RNA polymerases and chromatin remodelers with hexasomes motivated us to revisit this question. Here, we build on previous models to discuss how formation of hexasomes can allow sophisticated regulation of transcription and also significantly impact chromatin folding. We anticipate that further cellular and biochemical analysis of these subnucleosomal particles will uncover additional regulatory roles.

Indexed as

ChromatinNucleosomesDNA-Directed RNA PolymerasesChromatinDNA-Directed RNA PolymerasesNucleosomes

Identifiers

PMID38412564
PMCPMC11893180
OpenAlexW4392151118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.